About Rewrite Therapeutics
Rewrite Therapeutics is a company based in Reykjavik (Iceland) founded in 2020 was acquired by Intellia Therapeutics in February 2022.. Rewrite Therapeutics operates in a competitive market with competitors including Twist Bioscience, Nuclera Nucleics, Ansa Biotechnologies, Nutcracker Therapeutics and DNA Script, among others.
- Headquarter Reykjavik, Iceland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Intellia Therapeutics
(Feb 03, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rewrite Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rewrite Therapeutics
Rewrite Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Intellia Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics using CRISPR/Cas9 are developed for various diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rewrite Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rewrite Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rewrite Therapeutics Comparisons
Competitors of Rewrite Therapeutics
Rewrite Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Twist Bioscience, Nuclera Nucleics, Ansa Biotechnologies, Nutcracker Therapeutics and DNA Script, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
DNA synthesis technology using enzymes is provided.
|
|
| domain | founded_year | HQ Location |
mRNA therapeutics are developed via proprietary biochip platforms.
|
|
| domain | founded_year | HQ Location |
Benchtop DNA printers for nucleic acid synthesis are developed.
|
|
| domain | founded_year | HQ Location |
Developer of mRNA technology for therapeutics and vaccines
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Rewrite Therapeutics
When was Rewrite Therapeutics founded?
Rewrite Therapeutics was founded in 2020.
Where is Rewrite Therapeutics located?
Rewrite Therapeutics is headquartered in Reykjavik, Iceland.
What does Rewrite Therapeutics do?
Rewrite Therapeutics was established in 2020 and is headquartered in Reykjavik, Iceland. Focus is placed on the development of DNA polymerization technology within the biotechnology sector. This technology is designed for research purposes, enabling advancements in genetic applications. Operations are centered on innovation in molecular tools, with services provided to support scientific investigations in various research environments.
Who are the top competitors of Rewrite Therapeutics?
Rewrite Therapeutics's top competitors include Nuclera Nucleics, Twist Bioscience and Ansa Biotechnologies.
Who are Rewrite Therapeutics's investors?
Rewrite Therapeutics has 1 investor. Key investors include Intellia Therapeutics.